Turtle Creek Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Turtle Creek Wealth Advisors's VRTX Position: Q2 2026 in Review
Turtle Creek Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 7.6% in Q2 2026, buying an estimated $31.5K and bringing the position to 1,009 shares worth $501K. The position accounts for 0.03% of the portfolio, ranked #262.
Turtle Creek Wealth Advisors first reported a position in VRTX in Q4 2023 and has held it in 6 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Turtle Creek Wealth Advisors held 1,009 shares of Vertex Pharmaceuticals worth $501K as of Q2 2026.
- Turtle Creek Wealth Advisors bought 71 Vertex Pharmaceuticals shares in Q2 2026, an estimated $31.5K.
- Vertex Pharmaceuticals made up 0.03% of Turtle Creek Wealth Advisors's portfolio in Q2 2026, its #262 holding.
- Turtle Creek Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.